Assessment of the impact of procurement centralization on the drug provision for patients within the High-Cost Nosology Program in the Russian Federation

Assessment of the impact of procurement centralization on the drug provision for patients within the High-Cost Nosology Program in the Russian Federation

Background. In the Russian Federation, patients receive expensive drugs from the federal budget funds within High-Cost Nosology (HCN) Program.Objective: to assess the impact of drug procurement centralization on the weighted average price (WAP) per 1 unit of measurement (UM) of a drug, the procureme...

Full description

Saved in:
Bibliographic Details
Main Authors: V. V. Omelyanovskiy, V. A. Ryagina, A. G. Kharitonova, K. I. Matrenin, A. A. Kingshott, O. V. Ashikhmina, M. V. Zhirov
Format: Article
Language:Russian
Published: IRBIS LLC 2024-11-01
Series:Фармакоэкономика
Subjects:
high-cost nosologies
hcn
public procurement
regional drug provision program
federal drug provision program
Online Access:https://www.pharmacoeconomics.ru/jour/article/view/1089
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.pharmacoeconomics.ru/jour/article/view/1089

Similar Items